Nevan Krogan Wins France’s Highest Honor
Nevan Krogan Wins France’s Highest Honor
Gladstone investigator is awarded the Legion of Honor
Awards Krogan Lab1 - 15 of 64 Results Clear All
Gladstone investigator is awarded the Legion of Honor
Awards Krogan LabUCSF News—Nevan Krogan, PhD, a senior investigator at Gladstone and the director of the Quantitative Biosciences Institute at UC San Francisco, leads a vast, international collaborative effort to find drugs against COVID-19 called the QBI Coronavirus Research Group (QCRG). The group recently received $67.5 million from the National Institutes of Health, the largest such award in UCSF's history, to pursue work on coronaviruses and other viruses with pandemic potential.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabA new catalog to help better understand how HIV hijacks human cells
Research (Publication) HIV/AIDS Data Science and Biotechnology Genomic Immunology Virology Krogan Lab Marson LabGladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCsabc7 News—Senior Investigators Warner Greene, MD, PhD, and Nevan Krogan, PhD, discuss the possibility that Omicron, although more transmissible than previous SARS-CoV-2 variants, may cause less severe disease.
Gladstone Experts COVID-19 Center for HIV Cure Research Data Science and Biotechnology Virology Greene Lab Krogan LabABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava LabABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava LabWhile the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quickly
Gladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard LabGladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytes
News Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene EditingA Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene EditingA team of Gladstone and UCSF scientists used a large-scale genetic approach to map the structure of protein complexes in live cells
News Release Research (Publication) Data Science and Biotechnology Krogan Lab Protein InteractionThe new study points toward ways to treat not only COVID-19, but future coronaviruses that might emerge
News Release Research (Publication) COVID-19 Virology Krogan Lab Ott LabLife Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene EditingMedium—Senior Investigator Nevan Krogan, PhD, explains his group's recent discovery of the cellular processes the coronavirus commandeers to grow and propagate and how this information can be harnessed for drug development.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan LabSan Francisco Chronicle—Commenting on the disappointing recent reports about antibodies as barriers against coronavirus infection, Senior Investigator Nevan Krogan, PhD, and Visiting Scientist Danielle Swaney, PhD, emphasize the need for drug treatments as an alternative, and describe how they look for such treatments.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab